Email Medtest Medtest Headquarters Medtest Facebook Medtest Linkedin

MedTest announces the US Commercial Launch of their Direct Hemoglobin A1c, Homocysteine, and Lipoprotein (a) “Lp(a)” Reagents for the Mindray™ BS-480 Chemistry Analyzer

Mar 21, 2016 - press releases

(Canton, Michigan)  MedTest announces the commercial launch of their Direct Hemoglobin A1c, Homocysteine, and Lipoprotein (a) reagents for the Mindray BS-480 Chemistry Analyzer for use in clinical laboratories in the United States and Canada.  The Mindray BS-480 Analyzer meets the testing needs of mid-volume laboratories, while offering state-of-the-art features commonly found on large volume analyzers.

MedTest is the exclusive US distributor of the Mindray BS-480 Chemistry Analyzer, which is part of the MedTest 480 Ensemble that includes the manufacturing and distribution of reagents, calibrators, and quality control products for the general chemistry and drugs of abuse testing markets.  The full menu includes drugs of abuse reagents for urine drug screening, and a full menu of chemistry tests including specialty tests like Hemoglobin A1c and Lipoprotein (a).  The new reagents are manufactured specifically for the Mindray BS-480 Analyzer and are provided in barcoded containers for ease of use. 

Hanjoon Ryu, CEO of MedTest, stated: “MedTest is committed to test menu expansion on the Mindray BS-480 Analyzer.  Our customers deserve an integrated service provider who offers innovative instruments with expanding test menus, superior customer support and recognized economic advantages.  Partnered with the Mindray bench-top BS-200 Chemistry Analyzer, the Mindray BS-480 Analyzer enables MedTest to offer a unique testing solution for the Integrated Delivery Networks (IDNs) and Group Purchasing Organizations (GPOs) in the United States.  Our solution will provide commutable testing results between the core laboratory and satellite laboratory.”

About MedTest:  MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing.  In June 2013, MedTest acquired Pointe Scientific, a US-based company that has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981.  In the fall of 2014, MedTest acquired Clinitox Diagnostix, a company that manufactures and supports drug confirmatory testing via Liquid Chromatography/Mass Spectrometry (LC/MS).

For additional information:

MedTest
Debbie Whitehair, MT(ASCP)SC
Vice President, Marketing
484.748.1603
dwhitehair@medtest.com
www.medtest.com

PR-M3111-03   03/16

Mindray and MedTest announce FDA 510(k) Clearance for the BC-3600 Hematology Analyzer

Sep 15, 2015 - press releases

(Mahwah, New Jersey & Canton, Michigan) Mindray announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market and sell the new Mindray BC-3600 Auto Hematology Analyzer. The Mindray BC-3600 Analyzer meets the testing needs of small and mid-volume hematology laboratories while offering stateof-the-art features commonly found on large volume analyzers.

The BC-3600 Hematology Analyzer features closed-tube sampling via a single push button. The large 10.4 inch color touchscreen allows maximum visibility from all angles. Hemoglobin analysis is performed using cyanide-free reagents. The analyzer processes up to 60 samples per hour and stores up to 40,000 results with histograms. The barcode reader and optional LIS connectivity enables seamless sample data transmission. Nearly all scheduled maintenance procedures are
automated by touch buttons. The intuitive software enhances workflow efficiency and offers the operator a pleasant user experience.

Caroline Li, General Manager of Mindray IVD North America, stated: “We are excited to launch the BC-3600 Hematology Analyzer into the United States laboratory market. Mindray enjoys satisfied customer experiences with this analyzer outside of the US and looks forward to adding US customers to our installed base. As Mindray has grown rapidly in global markets, the commercialization of the BC-3600 Hematology Analyzer further enhances our presence in the US in-vitro diagnostic
market enabling us to continue to introduce new and innovative products for the clinical laboratory in the future.”

MedTest is the exclusive primary distributor of the BC-3600 Hematology Analyzer in the US and Canada. Hanjoon Ryu, CEO of MedTest, stated: “Low and Mid-volume laboratories desire a provider who offers innovative instruments with proven quality reagents, superior customer support and recognized economic advantages across multiple laboratory disciplines. Partnered with the bench-top BS-200 Chemistry Analyzer or the BS-480 Chemistry Analyzer, the addition of the
BC-3600 Hematology Analyzer enables MedTest to offer a total testing solution that meets the requirements of both the hematology and chemistry laboratories. We are delighted to share this announcement with our strategic partner, Mindray.”

About Mindray: Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains the global headquarters in Shenzhen, China, the U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From the main manufacturing and engineering base in China, Mindray supplies through our worldwide distribution network a broad range of products across three primary business segments, namely
patient monitoring and life support, in-vitro diagnostic, and medical imaging systems.

About MedTest: MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing. In June 2013, MedTest acquired Pointe Scientific, a company that has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981. In the fall of 2014, MedTest acquired Clinitox Diagnostix, a company that manufactures and supports drug confirmatory testing via Liquid Chromatography/Mass Spectrometry (LC/MS).

For additional information:

MedTest Mindray
Debbie Whitehair, MT(ASCP)SC Caroline Li 
Vice President, Marketing General Manager of  Mindray IVD North America
484.748.1603 800.288.2121 Ext. 2152
dwhitehair@medtest.com c.li@mindray.com
www.medtest.com www.mindraynorthamerica.com

PR-M1113-01   09/15

MedTest DX Launches Revised Website

Sep 15, 2015 - press releases

(Canton, Michigan) MedTest launched a major revision to its website today focused on products within the MedTest DX brand. Viewer’s ease of use in navigation and access to valuable information needed by the laboratory were the key drivers of the revision. What will you see when you view medtestdx.com?

  • New product descriptions titled Ensembles that include the instrument, test menu, consumables and service and support
  • Access to package inserts and SDS sheets
  • Instrument demo videos
  • New informational sections on topics like Drugs of Abuse and GPO’s & IDN’s
  • Displays adapt to viewers using computers, tablets, or smartphones

 

The portfolio of the MedTest DX brand features chemistry and hematology instruments manufactured by Mindray, the extensive chemistry menu and drugs of abuse screening menu, the SPOTCHEM EZ instrument and reagents from Arkray and various specialty reagents that are used as open-channel tests.

Hanjoon Ryu, CEO of MedTest, stated: “In today’s world, life revolves around information. Company websites must be easy to use and contain quality information relative to the viewer. Our revised website meets these two criteria. We focus on providing the most relevant information to our current and future laboratory customers.”

About MedTest: MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing. In June 2013, MedTest acquired Pointe Scientific, a company that has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981. In the fall of 2014, MedTest acquired Clinitox Diagnostix, a company that manufactures and supports drug confirmatory testing via Liquid Chromatography/Mass Spectrometry (LC/MS).

For additional information, please contact:

Debbie Whitehair, MT(ASCP)SC
Vice President, Marketing
484.748.1603
dwhitehair@medtest.com
www.medtest.com

PR-M2111-04   09/15

MedTest Holdings Announces a New Chief Financial Officer

Apr 6, 2015 - press releases

For Immediate Release: (Canton, Michigan) Effective April 1, 2015, Tim Allen has been appointed as the new Chief Financial Officer (CFO) by MedTest Holdings replacing Len Stigliano who is retiring effective April 30, 2015.

Mr. Allen has held various financial leadership roles during his career, most recently serving as Senior Vice President of Finance at Schawk, Inc. responsible for Global Operations, Planning and Investor Relations.  Prior to Schawk, he held financial leadership positions with Siemens and Dade Behring responsible for commercial operations, manufacturing, research and development, supply chain, and distribution.  Tim holds an MBA and BS degree from Purdue University majoring in Finance, Operations Management and Accounting.  He is also a Certified Public Accountant and a Certified Management Accountant.

Hanjoon Ryu, CEO of MedTest, stated: “Tim’s strong focus on our customers and his extensive experience in the in-vitro diagnostic industry enables him to lead MedTest through today’s challenging market and to strengthen our competitiveness for the future.  I want to express my sincere gratitude to Len Stigliano for his numerous contributions over the years and wish him a happy and fruitful retirement.”

About MedTest:  MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing.  In June 2013, MedTest acquired Pointe Scientific, a US-based company that has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981.  In October 2014, MedTest acquired Clinitox Diagnostix, a Canadian-based company, which provides drugs of abuse confirmatory testing capabilities via liquid chromatography/mass spectrophotometry (LC/MS) instrumentation and associated reagents and consumables as pre-packaged kits.  Implementation consulting provides the customer with on-site assistance in setting up their LC/MS testing and developing the standard operating procedures enabling the laboratory to initiate testing sooner and reduce costly start-up costs.

For additional information, please contact:

MedTest
Debbie Whitehair, MT(ASCP)SC
Vice President, Marketing
484-748-1603
dwhitehair@medtest.com
www.medtest.com

                                                              

PR-M3111-02   04/15

MedTest announces an Automated On-Board Lyse Application for Hemoglobin A1c (HbA1c) on the Mindray™ BS-200 Chemistry Analyzer

Feb 25, 2015 - press releases

For Immediate Release: (Canton, Michigan)  MedTest announces the availability of an application that enables whole blood samples to automatically be lysed on-board the Mindray™ BS-200 Chemistry Analyzer prior to analysis for Hemoglobin A1c (HbA1c).   The Mindray™ BS-200 Chemistry Analyzer, whose menu includes general chemistry and urine drugs of abuse screening tests, meets the testing needs of small-volume laboratories while offering state-of-the-art features commonly found on large volume analyzers.

MedTest is the exclusive US distributor of the Mindray™ BS-200 Chemistry Analyzer, including manufacturing and distribution of reagents, calibrators and quality control products for the general chemistry and drugs of abuse testing markets.  Automating the whole blood sample lyse procedure on-board the Mindray™ BS-200 Analyzer eliminates manual, off-line sample preparations resulting in significant timesaving and improving overall laboratory workflow.  The HbA1c assay on the Mindray™ BS-200 is CLIA classified as “moderately” complex.

Hanjoon Ryu, CEO of MedTest, stated: “We are pleased to be able to offer this solution for processing Hemoglobin A1c whole blood samples on the Mindray™ BS-200 analyzer.   Helping our customers meet their workflow efficiency goals is paramount to MedTest’s focus on delivering the “right” products and services to our laboratory customers.”

About MedTest:  MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing.  In June 2013, MedTest acquired Pointe Scientific, a US-based company that has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981.  In October 2014, MedTest acquired Clinitox Diagnostics, a Canadian company that offers drug confirmatory testing solutions via LC/MS.

For additional information, please contact:

MedTest
Debbie Whitehair, MT(ASCP)SC
Vice President, Marketing
484-748-1603
dwhitehair@medtest.com
www.medtest.com

                                                              

PR-M1111-01   02/15

PREV 1 2 3 4 5 NEXT